NEO NeoGenomics, Inc. Stock Quote

NEO [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-0.03	Insider Own	2.70%	Shs Outstand	111.50M	Perf Week	-9.88%
Market Cap	5.88B	Forward P/E	124.93	EPS next Y	0.41	Insider Trans	-28.14%	Shs Float	110.38M	Perf Month	-4.78%
Income	-4.90M	PEG	-	EPS next Q	0.04	Inst Own	90.80%	Short Float	4.99%	Perf Quarter	12.99%
Sales	425.30M	P/S	13.84	EPS this Y	-51.70%	Inst Trans	1.33%	Short Ratio	6.20	Perf Half Y	31.10%
Book/sh	6.23	P/B	8.18	EPS next Y	68.60%	ROA	0.50%	Target Price	64.60	Perf Year	85.28%
Cash/sh	2.57	P/C	19.87	EPS next 5Y	20.00%	ROE	0.70%	52W Range	20.47 - 61.57	Perf YTD	-5.33%
Dividend	-	P/FCF	-	EPS past 5Y	23.30%	ROI	0.30%	52W High	-17.22%	Beta	0.70
Dividend %	-	Quick Ratio	5.70	Sales past 5Y	34.80%	Gross Margin	41.90%	52W Low	149.00%	ATR	2.82
Employees	1700	Current Ratio	6.10	Sales Q/Q	17.90%	Oper. Margin	-3.60%	RSI (14)	38.09	Volatility	6.51% 4.81%
Optionable	Yes	Debt/Eq	0.25	EPS Q/Q	109.00%	Profit Margin	1.00%	Rel Volume	1.05	Prev Close	50.86
Shortable	Yes	LT Debt/Eq	0.24	Earnings	Feb 24 BMO	Payout	0.00%	Avg Volume	887.73K	Price	50.97
Recom	1.60	SMA20	-7.90%	SMA50	-6.53%	SMA200	23.25%	Volume	933,993	Change	0.22%

Feb-25-21

Resumed

Needham

Buy

$65

Feb-25-21

Downgrade

Raymond James

Outperform → Mkt Perform

Jan-28-21

Initiated

Truist

Buy

$65

Dec-11-20

Resumed

BTIG Research

Buy

$60

Oct-28-20

Reiterated

Needham

Buy

$39 → $46

Sep-09-20

Initiated

Morgan Stanley

Overweight

$46

Aug-28-20

Initiated

Guggenheim

Buy

$46

Jul-29-20

Reiterated

Needham

Buy

$33 → $39

Jun-25-20

Initiated

BofA/Merrill

Buy

$34

Apr-21-20

Resumed

Stephens

Overweight

$33

Mar-02-20

Resumed

Craig Hallum

Buy

$38

Feb-28-20

Upgrade

First Analysis Sec

Outperform → Strong Buy

Jan-23-20

Downgrade

First Analysis Sec

Strong Buy → Outperform

$29 → $35

Oct-30-19

Reiterated

Needham

Buy

$27 → $29

May-01-19

Reiterated

Needham

Buy

$22 → $24

Mar-29-19

Reiterated

Needham

Buy

$19 → $22

Jan-03-19

Initiated

Needham

Buy

$14

Oct-24-18

Upgrade

First Analysis Sec

Outperform → Strong Buy

$18

Aug-21-18

Initiated

Leerink Partners

Outperform

$18

May-02-18

Downgrade

First Analysis Sec

Overweight → Equal-Weight

$11

Feb-25-21 07:00AM	NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference ACCESSWIRE -6.40%
Feb-24-21 02:30PM	Neogenomics Inc (NEO) Q4 2020 Earnings Call Transcript Motley Fool
07:01AM	NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter ACCESSWIRE
07:00AM	NeoGenomics Announces CEO Succession ACCESSWIRE
06:30AM	NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
01:44AM	Is NeoGenomics, Inc. (NASDAQ:NEO) Expensive For A Reason? A Look At Its Intrinsic Value Simply Wall St.
Feb-16-21 07:00AM	NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference ACCESSWIRE
Feb-05-21 07:00AM	NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021 ACCESSWIRE
Feb-04-21 07:00AM	Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials GlobeNewswire
07:00AM	Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials ACCESSWIRE
Feb-02-21 08:00AM	NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition PR Newswire
Jan-10-21 11:00AM	Bearish Bets: 2 Stocks You Should Consider Shorting This Week TheStreet.com
Jan-06-21 11:00PM	NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes ACCESSWIRE -6.36%
Jan-05-21 04:05PM	NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes ACCESSWIRE
Jan-04-21 07:30AM	NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference ACCESSWIRE
Dec-16-20 05:33PM	Is NEO A Good Stock To Buy Now? Insider Monkey
Nov-29-20 06:44AM	Top 10 Healthcare Stocks To Buy for the Future Insider Monkey
Nov-16-20 08:00AM	Neo Performance Materials, Inc. to Host Earnings Call ACCESSWIRE
Nov-13-20 04:05PM	NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020 ACCESSWIRE
Nov-09-20 07:00AM	NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests ACCESSWIRE
Oct-29-20 09:34AM	Earnings Beat: NeoGenomics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St.
Oct-28-20 10:58AM	NeoGenomics' (NASDAQ:NEO) Wonderful 433% Share Price Increase Shows How Capitalism Can Build Wealth Simply Wall St.
Oct-27-20 02:00PM	Neogenomics Inc (NEO) Q3 2020 Earnings Call Transcript Motley Fool
10:45AM	NeoGenomics (NEO) Surpasses Q3 Earnings Estimates Zacks
07:38AM	Recap: NeoGenomics Q3 Earnings Benzinga
07:00AM	NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter ACCESSWIRE
Oct-20-20 12:31PM	Analysts Estimate NeoGenomics (NEO) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-15-20 09:00AM	NeoGenomics (NEO) Looks Good: Stock Adds 5.5% in Session Zacks
Oct-13-20 01:31PM	Hedge Funds Are Piling Into NeoGenomics, Inc. (NEO) Insider Monkey
09:00AM	NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China ACCESSWIRE
Oct-01-20 07:00AM	NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020 ACCESSWIRE
Sep-10-20 04:05PM	NeoGenomics To Virtually Participate In Fireside Chat At The 18th Annual Morgan Stanley Global Healthcare Conference ACCESSWIRE
Sep-07-20 11:40AM	ANIK vs. NEO: Which Stock Is the Better Value Option? Zacks
Aug-31-20 05:00PM	(LD Micro) 360 Companies Set to Present this Week ACCESSWIRE
Aug-28-20 10:16AM	Benzinga's Top Upgrades, Downgrades For August 28, 2020 Benzinga
Aug-06-20 01:43PM	LD Micro: Announces Preliminary List of Presenters for the LD-500 ACCESSWIRE
Aug-05-20 11:11AM	NeoGenomics Slumps in Q2 but Readies for Second-Half Rebound Motley Fool
Jul-30-20 10:52AM	NeoGenomics, Inc. (NASDAQ:NEO) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates Simply Wall St.
Jul-28-20 01:30PM	Neogenomics Inc (NEO) Q2 2020 Earnings Call Transcript Motley Fool
10:34AM	Recap: NeoGenomics Q2 Earnings Benzinga
09:55AM	NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:59AM	What Can We Conclude About NeoGenomics' (NASDAQ:NEO) CEO Pay? Simply Wall St.
07:00AM	NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic ACCESSWIRE
Jul-21-20 12:31PM	Earnings Preview: NeoGenomics (NEO) Q2 Earnings Expected to Decline Zacks
Jul-20-20 07:00AM	NeoGenomics Announces Board Appointments ACCESSWIRE
Jul-12-20 06:12AM	3 Top Healthcare Stocks to Buy Right Now Motley Fool
Jul-04-20 08:18PM	Hedge Funds Are Souring On NeoGenomics, Inc. (NEO) Insider Monkey
Jul-01-20 07:00AM	NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020 ACCESSWIRE +7.36%
Jun-29-20 07:00AM	NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients ACCESSWIRE +6.93%
Jun-25-20 10:10AM	Benzinga's Top Upgrades, Downgrades For June 25, 2020 Benzinga +5.54%
Jun-18-20 12:27PM	Needham: 3 Conviction Buy Stocks to Snap up Now TipRanks
Jun-12-20 01:50AM	Edited Transcript of NEO earnings conference call or presentation 28-Apr-20 12:30pm GMT Thomson Reuters StreetEvents
Jun-10-20 06:44PM	Stocks Showing Improved Relative Strength: NeoGenomics Investor's Business Daily
Jun-02-20 04:05PM	NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference ACCESSWIRE
Jun-01-20 04:05PM	NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference ACCESSWIRE
May-26-20 07:20AM	NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference ACCESSWIRE
05:00AM	NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test ACCESSWIRE
May-19-20 12:00AM	Edited Transcript of NEO earnings conference call or presentation 27-Feb-20 1:30pm GMT Thomson Reuters StreetEvents
May-11-20 04:05PM	NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference ACCESSWIRE
May-09-20 11:47AM	2 Stocks to Buy and Hold for Decades Motley Fool
May-05-20 08:00AM	NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients ACCESSWIRE +6.30%
Apr-30-20 12:07PM	Here's Why NeoGenomics Is Tumbling Today Motley Fool -11.86%
06:00AM	NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes ACCESSWIRE
Apr-29-20 05:20PM	NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes ACCESSWIRE +10.90%
06:33AM	NeoGenomics Prioritizes the Public Good During COVID-19 Slowdown Motley Fool
Apr-28-20 04:00PM	Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript Motley Fool -7.63%
09:35AM	NeoGenomics (NEO) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:00AM	NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter ACCESSWIRE
Apr-27-20 04:00PM	Here's Why Invitae Stock Popped as Much as 13.2% Today Motley Fool
Apr-09-20 07:00AM	NeoGenomics Provides COVID-19 Business Update ACCESSWIRE
Apr-03-20 07:00AM	NeoGenomics Integrates HALO(R) From Indica Labs ACCESSWIRE -10.43%
Apr-01-20 07:00AM	NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 ACCESSWIRE
Mar-29-20 12:12PM	Hedge Funds Were Dumping NeoGenomics, Inc. (NEO) Before The Coronavirus Insider Monkey
Mar-27-20 07:58AM	How Does NeoGenomics, Inc.'s (NASDAQ:NEO) Earnings Growth Stack Up Against Industry Performance? Simply Wall St. -5.65%
Mar-02-20 07:00AM	NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization ACCESSWIRE
Mar-01-20 09:10AM	NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next Simply Wall St.
Feb-28-20 07:00AM	NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference ACCESSWIRE
Feb-27-20 09:55AM	NeoGenomics (NEO) Tops Q4 Earnings and Revenue Estimates Zacks -8.27%
07:08AM	NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter ACCESSWIRE
06:30AM	NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Feb-20-20 12:31PM	NeoGenomics (NEO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Feb-06-20 07:00AM	NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020 ACCESSWIRE
Feb-05-20 07:00AM	NeoGenomics Announces Leadership Appointments ACCESSWIRE
Jan-30-20 11:30AM	GEOPOLITICAL EVENTS TO CAST A LONG SHADOW: The February 6th Groundhog Investment Forum Examines the 2020 Outlook for Stocks in a Hyper-Headlines Year Business Wire
Jan-17-20 10:45AM	2020 OUTLOOK AND INSIGHTS: Investment Trends and Themes to be Highlighted at the Emerald Groundhog Day Investment Forum Business Wire
Jan-14-20 07:55AM	The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug Benzinga
Jan-10-20 08:40AM	NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million ACCESSWIRE
Dec-12-19 07:10PM	Did Hedge Funds Drop The Ball On NeoGenomics, Inc. (NEO) ? Insider Monkey
Nov-06-19 04:05PM	NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference ACCESSWIRE
07:00AM	Have Insiders Sold NeoGenomics, Inc. (NASDAQ:NEO) Shares Recently? Simply Wall St.
Nov-05-19 06:01PM	Edited Transcript of NEO earnings conference call or presentation 29-Oct-19 12:30pm GMT Thomson Reuters StreetEvents
Nov-01-19 11:34AM	Healthcare ETF (IHF) Tops in October: 5 Best Stocks Zacks
Oct-29-19 08:55AM	NeoGenomics (NEO) Tops Q3 Earnings and Revenue Estimates Zacks +11.98%
07:00AM	NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter ACCESSWIRE
Oct-24-19 02:07PM	Is NeoGenomics, Inc. (NEO) Going To Burn These Hedge Funds ? Insider Monkey
Oct-23-19 11:06AM	Is Now An Opportune Moment To Examine NeoGenomics, Inc. (NASDAQ:NEO)? Simply Wall St.
Oct-01-19 04:05PM	NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019 ACCESSWIRE
Sep-25-19 04:05PM	NeoGenomics To Present At 2019 Cantor Global Healthcare Conference ACCESSWIRE
Sep-17-19 07:49AM	Introducing NeoGenomics (NASDAQ:NEO), The Stock That Zoomed 298% In The Last Five Years Simply Wall St.
Sep-09-19 07:12AM	NeoGenomics Has Attractive Charts and Should Continue Its Uptrend TheStreet.com -7.62%

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, as well as laboratories in Switzerland and Singapore. It operates in two segments, Clinical Services and Pharma Services. The company's laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, academic centers, and other clinical laboratories. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services, which focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides morphologic analysis which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics, Inc. has a strategic collaboration with Inivata Limited for the commercialization of its InVisionFirst-Lung liquid biopsy test in the United States; and a strategic partnership with Parexel to advance the application of precision medicine in oncology clinical trial. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JONES STEVEN C	Director	Jan 07	Option Exercise	7.15	100,000	715,000	1,100,000	Jan 11 05:24 PM
JONES STEVEN C	Director	Jan 07	Option Exercise	11.79	17,286	203,835	90,218	Jan 11 05:24 PM
Weiss Lawrence Martin	Chief Medical Officer	Dec 14	Option Exercise	9.40	109,004	1,024,986	120,721	Dec 15 08:51 PM
Weiss Lawrence Martin	Chief Medical Officer	Dec 14	Sale	51.06	20,200	1,031,412	100,521	Dec 15 08:51 PM
JONES STEVEN C	Director	Dec 14	Sale	51.67	25,000	1,291,750	1,000,000	Dec 14 05:49 PM
BALLIET JENNIFER	VP and Chief Culture Officer	Dec 11	Option Exercise	8.03	15,000	120,450	39,980	Dec 11 05:57 PM
BALLIET JENNIFER	VP and Chief Culture Officer	Dec 11	Sale	49.99	15,000	749,850	24,980	Dec 11 05:57 PM
JONES STEVEN C	Director	Dec 11	Sale	50.52	25,000	1,263,000	1,025,000	Dec 14 05:49 PM
JONES STEVEN C	Director	Dec 10	Sale	50.30	20,000	1,006,000	1,050,000	Dec 14 05:49 PM
JONES STEVEN C	Director	Dec 07	Sale	49.45	45,658	2,257,788	1,070,000	Dec 07 06:23 PM
Johnson Kevin C	Director	Dec 04	Sale	47.88	24,683	1,181,822	30,983	Dec 07 06:19 PM
JONES STEVEN C	Director	Dec 04	Sale	48.07	64,394	3,095,420	1,115,658	Dec 07 06:23 PM
JONES STEVEN C	Director	Dec 03	Sale	48.03	19,948	958,102	1,180,052	Dec 07 06:23 PM
Bonello William	President, Informatics	Dec 02	Option Exercise	8.03	8,000	64,240	20,060	Dec 04 06:03 PM
Bonello William	President, Informatics	Dec 02	Sale	46.80	8,000	374,400	12,060	Dec 04 06:03 PM
CARDOZA GEORGE	President, Pharma Services	Nov 25	Option Exercise	7.52	77,074	579,596	447,976	Nov 25 06:04 PM
CARDOZA GEORGE	President, Pharma Services	Nov 25	Sale	45.48	77,074	3,505,326	370,902	Nov 25 06:04 PM
CARDOZA GEORGE	President, Pharma Services	Nov 24	Option Exercise	7.52	72,926	548,404	423,828	Nov 25 06:04 PM
CARDOZA GEORGE	President, Pharma Services	Nov 24	Sale	45.19	52,926	2,391,726	370,902	Nov 25 06:04 PM
VAN OORT DOUGLAS M	Chairman and CEO	Nov 16	Option Exercise	7.52	20,000	150,400	2,522,790	Nov 16 08:30 PM
HIPP RAYMOND R	Director	Nov 16	Sale	42.28	70,000	2,959,600	66,800	Nov 18 06:53 PM
VAN OORT DOUGLAS M	Chairman and CEO	Nov 16	Sale	42.34	100,000	4,234,000	2,422,790	Nov 16 08:30 PM
VAN OORT DOUGLAS M	Chairman and CEO	Nov 13	Option Exercise	7.52	358,752	2,697,815	2,621,542	Nov 16 08:30 PM
VAN OORT DOUGLAS M	Chairman and CEO	Nov 13	Sale	41.56	118,752	4,935,333	2,502,790	Nov 16 08:30 PM
VAN OORT DOUGLAS M	Chairman and CEO	Nov 12	Option Exercise	7.52	121,248	911,785	2,384,038	Nov 16 08:30 PM
VAN OORT DOUGLAS M	Chairman and CEO	Nov 12	Sale	42.18	121,248	5,114,241	2,262,790	Nov 16 08:30 PM
Pedulla Denise E	General Counsel	Nov 10	Option Exercise	7.85	15,000	117,750	58,988	Nov 12 06:00 PM
Pedulla Denise E	General Counsel	Nov 10	Sale	42.00	2,262	95,004	56,726	Nov 12 06:00 PM
JONES STEVEN C	Director	Sep 29	Sale	36.95	141,049	5,211,761	1,200,000	Sep 30 06:25 PM
JONES STEVEN C	Director	Sep 29	Sale	36.55	81,000	2,960,550	97,932	Sep 30 06:25 PM
JONES STEVEN C	Director	Sep 28	Sale	36.34	38,951	1,415,479	1,341,049	Sep 30 06:25 PM
JONES STEVEN C	Director	Sep 28	Sale	36.56	19,000	694,640	178,932	Sep 30 06:25 PM
CROWTHER BRUCE K	Director	Sep 24	Option Exercise	9.11	8,333	75,914	54,816	Sep 24 09:02 PM
CROWTHER BRUCE K	Director	Sep 24	Sale	35.01	8,333	291,738	46,483	Sep 24 09:02 PM
CROWTHER BRUCE K	Director	Sep 22	Sale	35.68	2,400	85,632	46,483	Sep 24 09:02 PM
JONES STEVEN C	Director	Sep 10	Sale	37.13	37,991	1,410,606	1,380,000	Sep 10 06:16 PM
JONES STEVEN C	Director	Sep 09	Sale	36.98	71,583	2,647,139	1,417,991	Sep 10 06:16 PM
JONES STEVEN C	Director	Sep 08	Sale	36.13	10,426	376,691	1,489,574	Sep 10 06:16 PM
CARDOZA GEORGE	President, Pharma Services	Aug 06	Option Exercise	7.15	100,000	715,000	433,402	Aug 10 06:19 PM
HANNAH ALISON L.	Director	Aug 06	Option Exercise	7.27	10,000	72,700	88,796	Aug 10 06:22 PM
CARDOZA GEORGE	President, Pharma Services	Aug 06	Sale	39.35	82,500	3,246,375	350,902	Aug 10 06:19 PM
Bonello William	President, Informatics	Aug 03	Option Exercise	7.57	22,000	166,442	34,060	Aug 04 06:33 PM
BALLIET JENNIFER	VP and Chief Culture Officer	Aug 03	Option Exercise	7.52	13,000	97,760	37,980	Aug 04 06:01 PM
Bonello William	President, Informatics	Aug 03	Sale	38.61	22,000	849,420	12,060	Aug 04 06:33 PM
BALLIET JENNIFER	VP and Chief Culture Officer	Aug 03	Sale	39.25	13,000	510,250	24,980	Aug 04 06:01 PM
SHOVLIN ROBERT J.	President, Clinical Services	Jul 30	Option Exercise	9.94	83,391	829,126	229,626	Aug 03 07:26 PM
SHOVLIN ROBERT J.	President, Clinical Services	Jul 30	Sale	38.17	81,356	3,105,359	148,270	Aug 03 07:26 PM
CROWTHER BRUCE K	Director	May 01	Option Exercise	4.78	10,000	47,800	46,185	May 04 05:34 PM
JONES STEVEN C	Director	Mar 13	Option Exercise	4.78	125,000	597,500	1,500,000	Mar 16 06:45 PM
SHOVLIN ROBERT J.	President, Clinical Services	Mar 04	Option Exercise	8.03	96,167	772,221	249,733	Mar 05 08:14 PM
SHOVLIN ROBERT J.	President, Clinical Services	Mar 04	Sale	30.86	98,093	3,027,150	151,640	Mar 05 08:14 PM
JONES STEVEN C	Director	Mar 02	Sale	28.77	297,300	8,554,252	30,476	Mar 04 07:17 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience